TELA stock forecast
Our latest prediction for TELA Bio, Inc.'s stock price was made on the Dec. 17, 2019 when the stock price was at 11.26$.
In the short term (2weeks), TELA's stock price should underperform the market by -8.05%. During that period the price should oscillate between -13.64% and +9.00%.
In the medium term (3months), TELA's stock price should underperform the market by -23.45%. During that period the price should oscillate between -23.37% and +4.46%.Get email alerts
About TELA Bio, Inc.
TELA Bio, Inc. is a commercial stage medical technology company. It focuses on designing, developing and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. The company offers a portfolio of advanced reinforced tissue matrices that improve clinical outcomes and reduce overall costs of care in hernia repair, abdominal wall reconstruction and plastic and reconstructive surgery. TELA Bio was founded by Antony Koblish and Maarten Persenaire on April 17, 2012 and is headquartered in Malvern, PA.
At the moment the company generates 13M USD in revenues.
On its last earning announcement, the company reported a loss of -2.21$ per share.
The book value per share is -0.79$
Three months stock forecastDec. 17, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|